Infectious Disease

Top Story

No advantage in adding meropenem to colistin for A. baumannii infections

No advantage in adding meropenem to colistin for <i>A. baumannii </i>infections
February 20, 2018
In the Journals

Recreational waterborne illnesses cost US more than $2 billion annually

February 20, 2018
Recreational waterborne illnesses present a substantial economic burden to the United States health care system, with an annual cost of at least $2.2 billion from 90…
In the Journals

Vesatolimod safe, well-tolerated in patients with chronic HBV

February 20, 2018
Vesatolimod was safe and well-tolerated in patients with chronic hepatitis B and demonstrated consistent dose-dependent pharmacodynamic induction of…

Opioid substitute kratom linked to Salmonella outbreak

February 20, 2018
The CDC linked a multistate outbreak of Salmonella infections to kratom, an unregulated herbal supplement the agency said is consumed for its stimulant effects and as…

New Jersey Health Foundation grants $50k to hepatitis B, E research

February 20, 2018
The New Jersey Health Foundation awarded a $50,000 Innovation Grant to Alexander Ploss, PhD, assistant professor of molecular biology at Princeton University, for…
More Headlines »
CME

HIV Curbside Consults – Volume II: Managing the HIV Patient with High Viral Load and Low CD4 Count

This activity is supported by an educational grant from ViiV Healthcare.

In this case-based video, Paul E. Sax, MD and Eric S. Daar, MD discuss the management of a newly diagnosed patient with…
More »
In the Journals Plus

Extending interferon treatment duration for chronic delta hepatitis improves outcomes

February 20, 2018
Interferon treatment lasting longer than 2 years for chronic delta hepatitis, or CDH, increases virologic response and…
More »
Resource Centers
IDWeek

IDWeek

Video
Meeting News

VIDEO: H7N9 a ‘virus of greatest concern’

October 18, 2017
More »